Xilio Therapeutics Inc (XLO) stock saw a decline, ending the day at $0.89 which represents a decrease of $-0.38 or -29.92% from the prior close of $1.27. The stock opened at $0.96 and touched a low of ...

Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Stoke Therapeutics in a research note issued to ...

Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Taysha Gene Therapies in a report issued on ...

NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), known for its efforts in combating obesity and maintaining ...

ISELIN, N.J. - Outlook Therapeutics, Inc. (NASDAQ:OTLK), a clinical-stage biopharmaceutical company with a current market capitalization of $52 million, reported at the Hawaiian Eye and Retina 2025 ...